John Thomas Mulligan

This inventor holds 32 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Biotechnology Research. Top assignees: Darwin Discovery Limited, Qiagen Genomics, Inc., Blue Heron Biotechnology, Inc.. Active years: 1992-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Thomas Mulligan. Retrieved from https://idiyas.com/inventor/john-thomas-mulligan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 4)

% Patents Active = 68.8

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 4)

Average Co-Inventor Count = 4.2

ph-index = 16

Forward Citations = 1,333(Granted Patents)

Location History:

Palo Alto, CA (US) (1992)
Seattle, WA (US) (2000 - 2023)

Company Filing History:

7 out of 90

Darwin Discovery Limited

patents

5 out of 9

Qiagen Genomics, Inc.

patents

3 out of 3

Blue Heron Biotechnology, Inc.

patents

4. 3 out of 4

Operon Biotechnologies, Inc.

patents

5. 2 out of 2

Bonum Therapeutics, Inc.

University of Washington

patents

13. 3 out of 834,708

Other

patents

Years Active: 1992-2025

Loading Chart...

Areas of Expertise:

Protein Complexes

Bone Mineralization

Nucleic Acid Sequencing

Automated Polymer Synthesis

Antibodies

Polynucleotide Production

Gene Products

Biological Assays

Sensitivity Enhancement

Wicking-Based Draining

Data Correlation

Bacterial Promoters

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12303567 - Compositions of protein complexes and methods of use thereof (2025-05-20),

2. 11642417 - Compositions of protein complexes and methods of use thereof (2023-05-09),

3. 10822605 - Method and apparatus for producing sequence verified DNA (2020-11-03),

4. 9791462 - Compositions and methods for increasing bone mineralization (2017-10-17),

5. 8986685 - Compositions and methods for increasing bone mineralization (2015-03-24),

6. 8580201 - Wicking-based reagent-solution draining in an automated system (2013-11-12),

7. 8361396 - Automated polymer-synthesis system (2013-01-29),

8. 7994299 - Compositions and methods for increasing bone mineralization (2011-08-09),

9. 7977312 - Compositions and methods for increasing bone mineralization (2011-07-12),

10. 7758858 - Antibodies associated with alterations in bone density (2010-07-20),

11. 7642344 - Methods and compositions for determining the sequence of nucleic acid molecules (2010-01-05),

12. 7572899 - Compositions and methods for increasing bone mineralization (2009-08-11),

13. 7482119 - Solid phase methods for polynucleotide production (2009-01-27),

14. 7285641 - Antibodies against gene products related to Werner's Syndrome (2007-10-23),

15. 7247434 - Methods and compositions for determining the sequence of nucleic acid molecules (2007-07-24),

Title: A Spotlight on John Thomas Mulligan's Contributions to Biotechnology

Introduction

John Thomas Mulligan is a prominent inventor based in Seattle, WA, with a remarkable portfolio of 31 patents. His innovative work primarily focuses on biotechnology, where he has made significant advancements through his patented inventions.

Latest Patents

Mulligan's latest notable patents illustrate his expertise in developing technologies that address complex biological challenges. One of his inventions, titled "Compositions of protein complexes and methods of use thereof," involves protein complexes that consist of a sensor domain and a therapeutic domain linked by a linker. This innovation highlights the activity of the therapeutic domain's dependence on the sensor domain binding to target markers. Another innovative patent, "Method and apparatus for producing sequence verified DNA," outlines a method for retrieving specific polynucleotide molecules from a mixture. This process includes synthesizing identifier regions on polynucleotide molecules and sequencing them to associate with corresponding IDs, enhancing the efficiency of genetic research and applications.

Career Highlights

Throughout his career, John Thomas Mulligan has worked with notable companies such as Darwin Discovery Limited and Qiagen Genomics, Inc. His role in these organizations has allowed him to contribute to high-impact research and development in the field of genomics and biotechnology. His extensive patent portfolio reflects his dedication to advancing scientific knowledge and practical applications in biotechnology.

Collaborations

Mulligan has collaborated with esteemed professionals in his field, including Jeffrey Van Ness and John C Tabone. These partnerships have further enriched his research and innovation capabilities, allowing for a diverse exchange of ideas and methodologies that ultimately benefit his inventions.

Conclusion

John Thomas Mulligan exemplifies the spirit of innovation through his substantial contributions to the field of biotechnology. With his impressive patent portfolio and collaborations, he continues to push the boundaries of what is possible in genetic research and therapeutic applications. His work is poised to have a lasting impact on the industry and inspire future generations of inventors.

Profile summary based on public USPTO records.